304873-80-1

Basic information

• Product Name: (4-formyl-cyclohexyl)-carbamic acid tert-butyl ester
• Synonyms: (4-formyl-cyclohexyl)-carbamic acid tert-butyl ester
• CAS NO: 304873-80-1
• Molecular Weight: 227.304
• Mol File: 304873-80-1.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 339.5±31.0 °C(Predicted)
• Density: 1.04±0.1 g/cm3(Predicted)
• CAS DataBase Reference: (4-formyl-cyclohexyl)-carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (4-formyl-cyclohexyl)-carbamic acid tert-butyl ester(304873-80-1)
• EPA Substance Registry System: (4-formyl-cyclohexyl)-carbamic acid tert-butyl ester(304873-80-1)

Safety Data

• Hazardous Substances Data: 304873-80-1(Hazardous Substances Data)

Upstream product

• 1776-53-0 4-aminocyclohexanecarboxylic acid 
• 24424-99-5 di-tert-butyl dicarbonate 
• 175867-59-1 methyl 4-aminocyclohexane-1-carboxylate 
• 503817-57-0 methyl 4-{[(tert-butoxy)carbonyl]amino}cyclohexane-1-carboxylate 
• 130309-46-5 trans-4-(tert-butoxycarbonylamino)cyclohexane carboxylic acid 

Downstream Products

• 947141-86-8 tert-butyl ((1r,4r)-4-ethynylcyclohexyl)carbamate 
• 1354280-36-6 C₁₄H₂₃N₃O₂ 
• 1354280-37-7 C₁₉H₃₁N₃O₄ 
• 1313365-97-7 4-(4-{[(4-iodo-phenyl)-methyl-amino]-methyl}-trans-cyclohexyl)-1-methyl-piperazin-2-one 
• 1313365-98-8 [[2-(tert-butoxycarbonyl-methyl-amino)-ethyl]-(4-{[(4-iodo-phenyl)-methyl-amino]-methyl}-trans-cyclohexyl)-amino]-acetic acid methyl ester 
• 1313365-94-4 (4-{[(4-iodo-phenyl)-methyl-amino]-methyl}-trans-cyclohexylamino)-acetic acid methyl ester 
• 1313365-62-6 (4-{[(4-iodo-phenyl)-methyl-amino]-methyl}-trans-cyclohexyl)-carbamic acid tert-butyl ester 
• 1313363-54-0 (S)-1-(4-chloro-phenyl)-7-isopropoxy-6-methoxy-2-(4-{methyl-[4-(4-methyl-3-oxo-piperazin-1-yl)-trans-cyclohexylmethyl]-amino}-phenyl)-1,4-dihydro-2H-isoquinolin-3-one 
• 1313365-58-0 {4-[(4-iodo-phenylamino)-methyl]-trans-cyclohexyl}-carbamic acid tert-butyl ester 
• 933759-41-2 trans-4-(1H-imidazol-2-yl)cyclohexylamine 
• 933759-41-2 cis-4-(1H-imidazol-2-yl)cyclohexylamine 

Relevant articles and documents

IRAK4 kinase inhibitor and preparation method thereof

The present invention provides a compound represented by a general formula I, and a pharmaceutically acceptable salt, a stereoisomer, an ester, a prodrug, a solvate and a deuterated compound thereof,and the compound is an IRAK4 kinase inhibitor, and can be used for prevention and/or treatment of IRAK4 related diseases, such as autoimmune diseases, inflammatory diseases, cancers, heteroimmune diseases, thromboembolism, atherosclerosis, myocardial infarction and metabolic syndrome.

SUBSTITUTED PYRAZOLO(1,5-A)PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

The invention provides substituted pyrazolo[l,5-a]pyrimidine and related organic compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat medical disorders, e.g., Gaucher disease, Parkinson's disease, Lewy body disease, dementia, or multiple system atrophy, in a patient. Exemplary substituted pyrazolo[l,5-a]pyrimidine compounds described herein include 5,7- dimethyl-N-phenylpyrazolo[l,5-a]pyrimidine-3-carboxamide compounds and variants thereof.

Total synthesis and absolute configuration of radiosumin, a strong trypsin inhibitor from the blue-green alga Plectonema radiosum

Radiosumin (1), a strong trypsin inhibitory dipeptide isolated from the freshwater blue-green alga Plectonema radiosum (NIES-515), was synthesized for the first time by use of the hetero Diels-Alder reaction, the Horner-Wadsworth-Emmons reaction, the Corey-Winter reaction, regioselective hydrogenation, and reduction with zinc and formic acid as key steps, which unambiguously determined the absolute configuration of the structurally unique and biologically intriguing aquatic natural product (1).